ARS Pharmaceuticals, Inc. (SPRY)
9.01
-0.06
(-0.66%)
USD |
NASDAQ |
Jun 01, 09:50
ARS Pharmaceuticals Total Assets (Quarterly) : 287.57M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 434.57M |
| Heron Therapeutics, Inc. | 246.22M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Anika Therapeutics, Inc. | 179.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 226.26M |
| Shareholders Equity (Quarterly) | 61.31M |
| Debt to Equity Ratio | 1.584 |
| Current Ratio | 4.943 |
| Net Debt Paydown Yield | -2.43% |